IL17A and inflammatory bowel disease: Certain studies have provided evidence that IL-17 maintains barrier integrity and limits excessive permeability through the IL-17 receptor (IL-17R) adaptor protein Act-1 in a murine inflammatory bowel disease (IBD) model (13).